BB
Beken Bio creates minimally invasive liquid biopsy tests that detect cancer biomarkers in blood before symptoms appear. Their proprietary 3D REVEAL™ engine uses a 3D cell growth platform and AI-driven protein signature analysis to identify tumor-specific extracellular vesicles. The resulting diagnostic assays aim to enable earlier treatment decisions and improve survival rates.
Updated 2 months ago
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CFunding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Beken Bio creates minimally invasive liquid biopsy tests that detect cancer biomarkers in blood before symptoms appear. Their proprietary 3D REVEAL™ engine uses a 3D cell growth platform and AI-driven protein signature analysis to identify tumor-specific extracellular vesicles. The resulting diagnostic assays aim to enable earlier treatment decisions and improve survival rates.